{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:06:50Z","timestamp":1779890810222,"version":"3.53.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Data on treatment durations for gram-negative bloodstream infections in clinical practice are limited. In this study of 4240 gram-negative bloodstream infection episodes during 2019 from 24 US hospitals, the median duration of therapy was 12 days (IQR, 9\u201315); 59% were treated for &amp;gt;10 days. There was marked variability in treatment durations across hospitals.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf298","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T17:22:22Z","timestamp":1747329742000},"source":"Crossref","is-referenced-by-count":3,"title":["Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated With Prolonged Durations"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1476-1746","authenticated-orcid":false,"given":"Jesse D","family":"Sutton","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Veterans Affairs Salt Lake City Health Care System , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Utah Health , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-9132","authenticated-orcid":false,"given":"Katelyn S","family":"Quartuccio","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Rochester Medical Center\u2013Highland Hospital , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCoy","sequence":"additional","affiliation":[{"name":"Beth Israel Lahey Health Pharmacy , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester Medical Center\u2013Highland Hospital , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judianne C","family":"Slish","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Rochester Medical Center\u2013Highland Hospital , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew W","family":"Engers","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Trinity Health Ann Arbor , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag N","family":"Malani","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Trinity Health Ann Arbor , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-5549","authenticated-orcid":false,"given":"Sara M","family":"Karaba","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-886X","authenticated-orcid":false,"given":"Kelly E","family":"Pillinger","sequence":"additional","affiliation":[{"name":"PRIME Education , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-6324","authenticated-orcid":false,"given":"Pranita D","family":"Tamma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Denver Health , Denver, Colorado ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"2025062505200594500_ofaf298-B1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025062505200594500_ofaf298-B2","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2020.6348","article-title":"Effect of C-reactive protein\u2013guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial","volume":"323","author":"von Dach","year":"2020","journal-title":"JAMA"},{"key":"2025062505200594500_ofaf298-B3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cmi.2021.09.001","article-title":"Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by enterobacterales: a randomized, controlled trial","volume":"28","author":"Molina","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025062505200594500_ofaf298-B4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"BALANCE Investigators","year":"2024","journal-title":"N Engl J Med"},{"key":"2025062505200594500_ofaf298-B5","doi-asserted-by":"crossref","first-page":"101750","DOI":"10.1016\/j.eclinm.2022.101750","article-title":"Duration of antibiotic treatment for gram-negative bacteremia\u2014systematic review and individual participant data (IPD) meta-analysis","volume":"55","author":"Turjeman","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025062505200594500_ofaf298-B6","doi-asserted-by":"crossref","first-page":"ofab434","DOI":"10.1093\/ofid\/ofab434","article-title":"Optimizing the management of uncomplicated gram-negative bloodstream infections: consensus guidance using a modified Delphi process","volume":"8","author":"Heil","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025062505200594500_ofaf298-B7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J R Soc Med"},{"key":"2025062505200594500_ofaf298-B8","doi-asserted-by":"crossref","first-page":"dlac058","DOI":"10.1093\/jacamr\/dlac058","article-title":"Is shorter always better? The pros and cons of treating gram-negative bloodstream infections with 7 days of antibiotics","volume":"4","author":"Yahav","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2025062505200594500_ofaf298-B9","doi-asserted-by":"crossref","first-page":"ofad265","DOI":"10.1093\/ofid\/ofad265","article-title":"Epidemiology of gram-negative bloodstream infections in the United States: results from a cohort of 24 hospitals","volume":"10","author":"Ince","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025062505200594500_ofaf298-B10","doi-asserted-by":"crossref","first-page":"e2349864","DOI":"10.1001\/jamanetworkopen.2023.49864","article-title":"Transition to oral antibiotic therapy for hospitalized adults with gram-negative bloodstream infections","volume":"7","author":"Engers","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025062505200594500_ofaf298-B11","doi-asserted-by":"crossref","first-page":"106802","DOI":"10.1016\/j.ijantimicag.2023.106802","article-title":"Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians","volume":"61","author":"Isler","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2025062505200594500_ofaf298-B12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CCM.0000000000001393","article-title":"Duration of antimicrobial treatment for bacteremia in Canadian critically ill patients","volume":"44","author":"Daneman","year":"2016","journal-title":"Crit Care Med"},{"key":"2025062505200594500_ofaf298-B13","doi-asserted-by":"crossref","first-page":"e02495-18","DOI":"10.1128\/AAC.02495-18","article-title":"A systematic review and meta-analysis of antibiotic treatment duration for bacteremia due to Enterobacteriaceae","volume":"63","author":"Tansarli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025062505200594500_ofaf298-B14","doi-asserted-by":"crossref","first-page":"dlac005","DOI":"10.1093\/jacamr\/dlac005","article-title":"Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of gram-negative bloodstream infections","volume":"4","author":"Thaden","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2025062505200594500_ofaf298-B15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijantimicag.2011.07.016","article-title":"Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists","volume":"38","author":"Daneman","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"2025062505200594500_ofaf298-B16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkg447","article-title":"Variability of treatment duration for bacteraemia in the critically ill: a multinational survey","volume":"52","author":"Corona","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025062505200594500_ofaf298-B17","doi-asserted-by":"crossref","first-page":"ofz490","DOI":"10.1093\/ofid\/ofz490","article-title":"Impact of an antimicrobial stewardship bundle for uncomplicated gram-negative bacteremia","volume":"6","author":"Erickson","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025062505200594500_ofaf298-B18","doi-asserted-by":"crossref","first-page":"ofac488","DOI":"10.1093\/ofid\/ofac488","article-title":"Impact of a multistep bundles intervention in the management and outcome of gram-negative bloodstream infections: a single-center \u201cproof-of-concept\u201d study","volume":"9","author":"Bavaro","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025062505200594500_ofaf298-B19","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1017\/ash.2025.4","article-title":"Standardization in the management of gram-negative bloodstream infections after implementation of a clinical care guideline at a large academic, safety-net institution: a quasi-experimental study","volume":"12","author":"Deaney","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025062505200594500_ofaf298-B20","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/tri.14144","article-title":"Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation","volume":"34","author":"Avni-Nachman","year":"2021","journal-title":"Transpl Int"},{"key":"2025062505200594500_ofaf298-B21","doi-asserted-by":"crossref","first-page":"e14085","DOI":"10.1111\/tid.14085","article-title":"Evaluating antimicrobial duration for gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation","volume":"25","author":"Ranganath","year":"2023","journal-title":"Transpl Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf298\/63198401\/ofaf298.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/6\/ofaf298\/63198401\/ofaf298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/6\/ofaf298\/63198401\/ofaf298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:20:18Z","timestamp":1750843218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf298\/8133149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf298","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,15]]},"article-number":"ofaf298"}}